Researchers have identified a new molecular pathway for the regulation of bone and energy metabolism that challenges the conventional view of the role of leptin in bone turnover.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yadav, V. K. et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138, 976–989 (2009).
Forbes, A. P. Fuller Albright: his concept of postmenopausal osteoporosis and what came of it. Clin. Orthop. Relat. Res. 269, 128–141 (1991).
Ettinger, B. et al. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. J. Clin. Endocrinol. Metab. 83, 2239–2243 (1998).
Weng, M. Y. & Lane, N. E. Medication-induced osteoporosis. Curr. Osteoporos. Rep. 4, 139–145 (2007).
Ducy, P. et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197–207 (2000).
Ferron, M., Hinoi, E., Karsenty, G. & Ducy, P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl Acad. Sci. USA 105, 5266–5270 (2008).
Adachi, J. D. Glucocorticoid-induced osteoporosis. Osteoporos. Int. 20 (Suppl. 3), 239–240 (2009).
Rosen, C. J. Serotonin rising—the bone–brain–bowel connection. N. Engl. J. Med. 360, 957–959 (2009).
Warden, S. J., Robling, A. G., Sanders, M. S., Bliziotes, M. M. & Turner, C. H. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 146, 685–693 (2005).
Yadav, V. K. et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135, 825–837 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Rosen, C. Serotonin, leptin and the central control of bone remodeling. Nat Rev Rheumatol 5, 657–658 (2009). https://doi.org/10.1038/nrrheum.2009.231
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2009.231